$AMLX Cashflow Statement | Understand Stock

$AMLX

$27.09 -$0.11 (0.4%) Close

$AMLX Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022
Cash flows used in operating activities:
Net loss
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation expense
Depreciation expense
Accretion of investment discounts, net
Inventory impairment and loss on firm purchase commitments
Property and equipment impairment
Charge for purchase of IPR&D assets
Other non-cash items
Changes in operating assets and liabilities:
Accounts receivable, net
Inventories
Interest receivable
Prepaid expenses and other current assets
Operating lease right-of-use assets
Other assets
Deposits and other assets
Accounts payable
Accrued expenses and deferred rent
Accrued expenses
Operating lease liabilities
Net cash used in operating activities
Cash flows provided by investing activities:
Purchases of property and equipment
Purchases of IPR&D assets, including transaction costs
Purchases of investments
Proceeds from maturities of marketable securities
Net cash provided by investing activities
Cash flows provided by financing activities:
Proceeds from initial public offering
Proceeds from follow-on offering
Initial public offering costs paid
Follow-on offering costs paid
Proceeds from exercise of stock options
Proceeds from financings, net of issuance costs
Proceeds from exercise of stock options and RSUs vesting
Withholding taxes paid on stock-based awards
Net cash provided by financing activities

Effect of exchange rate changes on cash, cash equivalents and restricted cash equivalents
Net increase (decrease) increase in cash, cash equivalents and restricted cash equivalents
Cash, cash equivalents and restricted cash equivalents, beginning of year
Cash, cash equivalents and restricted cash equivalents, end of year
Reconciliation of cash, cash equivalents and restricted cash equivalents:
Cash and cash equivalents
Restricted cash equivalents
Total cash, cash equivalents and restricted cash equivalents:
Supplemental disclosure of cash flow information:
Unrealized gain (loss) on short-term investments
Taxes withheld on stock-based awards included in accrued expenses
Purchases of property and equipment included in accounts payable
Right-of-use assets and liabilities upon ASC842 adoption
Income taxes paid
Other assets included in accounts payable and accrued expenses
Right-of-use assets obtained in exchange for new operating lease liabilities
Movement of deferred offering costs to equity
Follow-on offering costs included in accounts payable and accrued expenses
Conversion of preferred stock to common stock upon initial public offering

Comments